Comparison between Quanti-FERON-TB Gold In-Tube test and tuberculin skin test for diagnosis of latent tuberculosis in children: A cross-section study

Keyghobad Ghadiri; Alisha Akya; Maryam Janatolmakan; Mansour Rezaei; Seyed Amirabbas Sharif; Shahla Masoomshahi; Raha Khosravi; Roya chegenelorestani

doi:10.4103/2221-6189.281321

ORIGINAL ARTICLE

Year : 2020 | Volume : 9 | Issue : 2 | Page : 73-77

Comparison between Quanti-FERON-TB Gold In-Tube test and tuberculin skin test for diagnosis of latent tuberculosis in children: A cross-section study

Keyghobad Ghadiri¹, Alisha Akya¹, Maryam Janatolmakan², Mansour Rezaei³, Seyed Amirabbas Sharif⁴, Shahla Masoomshahi², Raha Khosravi⁵, Roya chegenelorestani¹
¹ Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
² Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
³ Social Development and Health Promotion Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
⁴ Infectious Diseases Research Centre, Kashan University of Medical Sciences, Kashan, Iran
⁵ Pediatric Pathology Research Center, Research Institute for Children Health, Mofid Children Hospital, Shahid Behehsti University of Medical Sciences, Tehran, Iran

Date of Submission	06-Aug-2019
Date of Decision	11-Mar-2020
Date of Acceptance	12-Mar-2020
Date of Web Publication	28-Mar-2020

Correspondence Address:
Roya chegenelorestani
Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah
Iran

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2221-6189.281321

Abstract

Objective: To compare Quanti-FERON-TB Gold In-Tube (QFT- GIT) test and tuberculin skin test (TST) for the diagnosis of latent tuberculosis infection in children.
Methods: In this cross-sectional study, 64 participants who were between 3 months and 14 years old and had close contact with smear-positive pulmonary tuberculosis were included. Both QFT- GIT test and TST were done and the results were analyzed by SPSS software and Kappa test.
Results: The distribution of gender and age according to QFT-GIT and TST results were matched (P>0.05). Overall agreement between QFT-GIT and TST for diagnosis of latent tuberculosis infection in children was 75%. In addition, the contingency coefficient was 0.257, and the Kappa measure of agreement was 0.246 (P=0.034).
Conclusions: Compared to TST, QFT-GIT shows no apparent advantage for diagnosis of latent tuberculosis infection in children.

Keywords: Tuberculosis; Latent tuberculosis infection; Tuberculin skin test; Quanti FERON

How to cite this article:
Ghadiri K, Akya A, Janatolmakan M, Rezaei M, Sharif SA, Masoomshahi S, Khosravi R, chegenelorestani R. Comparison between Quanti-FERON-TB Gold In-Tube test and tuberculin skin test for diagnosis of latent tuberculosis in children: A cross-section study. J Acute Dis 2020;9:73-7

How to cite this URL:
Ghadiri K, Akya A, Janatolmakan M, Rezaei M, Sharif SA, Masoomshahi S, Khosravi R, chegenelorestani R. Comparison between Quanti-FERON-TB Gold In-Tube test and tuberculin skin test for diagnosis of latent tuberculosis in children: A cross-section study. J Acute Dis [serial online] 2020 [cited 2022 May 22];9:73-7. Available from: https://www.jadweb.org/text.asp?2020/9/2/73/281321

1. Introduction

Tuberculosis still remains a major global health problem, and the World Health Organization declared it a global health emergency in 1993^[1]. According to the WHO Global Tuberculosis Report in 2012, there were 8.7 million new cases and 1.4 million deaths in 2011. There were 500 000 cases and 64 000 deaths among children ^[1],[2]. Transmission of tuberculosis is person to person, usually by airborne droplets among adolescents or adults ^{[2],[3],[4],[5]}. Children are rarely infected ^[6],[7],[8] and they may harbor dormant organisms lifelong, which constitute a long-lasting reservoir of tuberculosis in the population. Latent tuberculosis infection (LTBI) occurs after inhalation of mycobacterium tuberculosis organism. Infected people are usually asymptomatic with normal chest radiography but tuberculosis skin test (TST) or interferon-gamma release assay (IGRA) is positive ^{[9],[10],[11]}. Accurate diagnosis of LTBI is critical for tuberculosis control strategies, especially in children and immune- deficient patients ^{[12],[13],[14]}. The hallmark of LTBI was positive TST and the absence of clinical and radiologic manifestations ^{[1],[2],[15],[16],[17]}. TST or the Mantoux test is the intradermal injection of purified protein derivative (PPD) that is stabilized with Tween 80. After 48-72 h of infection, the diameter of skin induration around the injection spot will be measured. The sensitivity and specificity of TST is variable according to the prevalence of tuberculosis infections ^{[14],[18],[19],[20]}. If the test is applied to a population with low prevalence of infection, its positive predictive value is low. Two new blood tests T-SPOT. TB and Quanti FERON-TB (QFT-GIT) have been developed that can diagnose LTBI by measuring the interferon released by patients’ T cells in response to mycobacterium tuberculosis antigens (TB7.7, ESAT-6 and CFP-10)^{[9],[10],[19],[21]}. The two new emerging tests have a high specificity in the low prevalence regions but they are more expensive and with limitations for certain groups of patients including children and immune-compromised patients ^{[11],[13],[20],[22]}. Although TST has been used for a long time for diagnosis of LTBI, recently IGRA has been developed. This test measures interferon-γ production by the patient’s T cells in response to stimulation by Mycobacterium tuberculosis antigens ^[23],[24]. Although a number of studies have evaluated the IGRA and TST in adults, the number of studies on children is limited ^{[23],[24],[25]}. The aim of this study was to compare QFT-GIT (one IGRA test) and TST for diagnosis of LTBI in children.

2. Participants and Methods

2.1. Participants

A cross-sectional study was carried out on 3 months to 14 years old children at Infectious Diseases Research Center (affiliated with Kermanshah University of Medical Sciences, Kermanshah, Iran). Altogether, 64 children who had close contact for weeks with their families with positive pulmonary tuberculosis were included in this study [Figure 1]. Participants had a history of Bacilli Calmette- Guerin (BCG) vaccination at birth. After the complete description of the study protocol and objectives, informed consents were obtained from all participants. This study was approved by the Ethics Committee of the Kermanshah University of Medical Sciences (approval number: 89181).

Figure 1: The study flowchart.

Click here to view

2.2. Evaluation and monitoring of children

A standard questionnaire was completed for each patient including gender, age, tuberculosis contact, socioeconomic status, and history of BCG vaccination. All of the participants underwent a normal thorough physical examination, and a normal chest X-ray. Both results were asymptomatic. Latent TBI infection was defined as close contact with smear-positive pulmonary tuberculosis but without clinical or radiological manifestation.

The tuberculin (Mantoux) test was performed by intradermal injection of 0.1 mL of PPD (Razi Institute, Iran) into the most superficial layer of the epidermis on the forearm. The reading was done 48-72 h after the injection, and indurations were measured. According to the manufacturer’s instructions (Cellestis Company, Australia), QFT-GIT test was also done for the blood samples of all participants. The test antigens consisted of two mixtures of ESAT6 and CFP10 proteins.

2.3. Statistical analysis

Statistical analysis was performed using SPSS 16 (SPSS Inc, Chicago, IL, USA). Chi-square or Fisher exact test was used to compare gender, socioeconomic status and age between the positive or negative results of TST and QFT-GIT test. The measure of agreement Kappa was used to determine the agreement rate between TST and QFT-GIT test. The significance level of the tests was set at α=0.05.

3. Results

A total of 64 participants of 3 months to 14 years old were included in our study. Among them, 33 children (51.6%) were boys and 31 (48.4%) were girls. In addition, 16 participants (25.0%) were under 4 years old, and only 7 participants (10.9%) had good socioeconomic status. There was no significant difference between QFT-GIT results according to the sex (P=0.577) and age (P=0.100). But it is significantly different between socioeconomic status (P=0.018) and QFT-GIT results. Also, there were no significant difference between TST results according to gender (P=0.100) and age (P=0.430). But it was significantly different between SES (P=0.002) and TST results.

Of the total 64 participants, 9 persons had positive QFT-GIT and 17 had PPD greater or equal 10 mm. The concordance (or agreement) percent between TST and QFT-GIT test was 75% and the Kappa rate (measure of agreement) was 0.246 (P=0.034). The 7.8% of the two tests were both positive and 67.2% were negative [Table 1]. According to the some categories (2 age groups, 3 levels of SES, and 2 genders), the agreement percent between TST and QFT-GIT test in moderate SES (84.5%), Age ≤4 years (77.5%), and girls (77.5%) were more than other categories. Also, the agreement measures of Kappa rate were higher in these three categories (0.376, 0.239, & 0.239, respectively) [Table 2].

Table 1: Comparison between results of TST test and QFT-GIT.

Click here to view

Table 2: Concordance rate and agreement rate between TST test and QFTGIT test according to age, sex and socioeconomic status categories.

Click here to view

4. Discussion

Iran is a country with a high rate of tuberculosis exposure and BCG vaccination. LTBI patients are not well screened and treated, but in some cases, screening and treatment of LTBI are performed by using TST. Our study showed that there is no superiority of QFT-GIT over TST for the diagnosis of LTBI and overall concordance between the two tests was 75% in children.

Jennifer et al. showed that QFT-GIT is a specific test for tuberculosis in children in low endemic areas, but there is a need for prospective long-term evaluation studies ^[26]. According to their findings, there was an excellent correlation between negative TST results and negative QFT-GIT results, but only 23% of children with positive TST had positive QFT-GIT. In our study, the agreement between the negative results was 67.2% and 29% of children with positive TST had positive QFT-GIT.

Bamford et al. by doing a retrospective analysis of data from children investigated for active tuberculosis at six large UK pediatric centers, found that the negative IGRA does not indicate active tuberculosis but using both TST and IGRA can increase the sensitivity for diagnosis of active tuberculosis ^[27]. In our study, 67.2% of children with negative TST had negative QFT-GIT.

According to an Australian survey done among healthcare workers with a low prevalence of tuberculosis and a significant rate of BCG vaccination, a positive QFT-GIT was associated with the prevalence of known risk factors for tuberculosis exposure while a positive TST was associated with a prior BCG vaccination. The concordance between TST and QFT-GIT was 75% but our study was done in an area with a high prevalence of tuberculosis and all the participants in our study had a positive history of BCG vaccination ^[28].

Another survey in Spain revealed that the incidence of LTBI in health care workers is 11.2% and there is an agreement between QFT-GIT and TST especially when the results of both tests are negative ^[29]. Our study also revealed that there is a high agreement when results of both tests are negative (67.2%), but in a study in Brazil, 55.6% of 261 household tuberculosis contacts had positive results tested by TST, while 43.1% of 298 who tested by IGRA, had positive results ^[30]. They concluded that TST+/IGRA- and TST+/IGRAT groups shared more similar characteristics, so in a tuberculosis-endemic area, TST appears to be more suitable when making the decision to treat latent tuberculosis infection. Their conclusion is similar to our study.

Vaziri et al. in a survey among 67 hospital nurses, concluded a 63.7% agreement between QFT-GIT and TST in the diagnosis of LTBI and there is no superiority of QFT-GIT over TST, but, TST is more suitable considering the high cost of QFT-GIT. The result of their study among adults is also similar to our study in children with LTBI ^[31]. According to Pollock et al., QFT assay may identify those at higher reactivation risk rather than all previously infected co-workers, so a negative QFT assay should be interpreted with caution ^[32].

Many studies have shown that there is a different concordance among QFT and TST in general and in situ ations when both are positive. Annie et al.^[33] showed high overall concordance between the two tests in HIV-infected individuals, but agreement among subjects with positive tests with either modality was low. In addition, Carvalho et al.^[34] showed that the agreement was 100% for TST negative results but only 34% for TST positive ones. Total agreement between QFT and TST in their study was 71%. In our study, 29% of subjects with positive TST had positive QFT results. When QFT was negative and TST was positive, the disagreement was 18.8%, and when TST was negative and QFT was positive, it was 6.2%

According to this study, it seems that QFT -GIT has no superiority over TST for diagnosis and detection of LTBI in children, and TST seems to be more suitable considering the cost.

Conflict of interest statement

The authors report no conflict of interest.

Acknowledgments

We would like to thank the Clinical Development Research Unit of Imam Reza Hospital the Kermanshah University of Medical Sciences Pulmonary Diseases.

Authors’ contribution

K.G.: Study concept and design; R.C., M.J. and S.M.: Acquisition of data; M.R.: Analysis and interpretation of data; A.A. and R.C.: Drafting of the manuscript, critical revision of the manuscript for important intellectual content; M.R.: Statistical analysis; S. A.S.: Administrative, technical, and material support; A.A. and K.G.: Study supervision.

References

1.	WHO. Global tuberculosis report 2012. [Online] Available from: https://www.who.int [Accessed on October 17th 2012].
2.	Starke JR, Munoz FM. Tuberculosis. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, (eds). Nelson text book of pediatrics. 18th ed. Philadelphia: WB Saunders; 2007, p.1240-1254.
3.	Aznar J, Safi H, Romero J, Alejo A, Gracia A, Palomares JC. Nosocomial transmission of tuberculosis infection in pediatrics wards. Pediatr Infect Dis J 1995; 14 (1): 44-48.
4.	George RH, Gully PR, Gill ON, Inness JA, Bakhshi SS, Connolly M. An outbreak of tuberculosis in a children’s hospital. J Hosp infect 1986; 8 (2): 129-142.
5.	Weinstein JW, Barrett CR, Baltimore RS, Hierholzer WJ Jr. Nosocomial transmission of tuberculosis from a hospital visitor on a pediatric ward. Pediatr Infect Dis J 1995; 14 (3): 232-234.
6.	Walgreen A. On contagiousness of childhood tuberculosis. Acta Pediatr 1937; 22: 229-234.
7.	Munoz FM, Ong LT, Seavy D, Medina D, Correa A, Starke JR. Tuberculosis among adult visitors of children with suspected tuberculosis and employees at a children’s hospital. Infect Control Hosp Epidemiol 2002; 23 (10): 568-572.
8.	Oh P, Granich R, Scott J, Sun B, Joseph M, Stringfield C, et al. Human exposure following Mycobacterium tuberculosis infection of multiple animal species in metropolitan zoo. Emerg Infect Dis 2002; 8 (11): 12901293.
9.	Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest 2012; 142 (1): 63-75.
10.	Chiappini E, Accetta G, Bonsignori F, Boddi V, Galli L, Biggeri A, et al. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis. Int J Immunopathol Pharmacol 2012; 25 (3): 557-564.
11.	Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganthan SC. A three-way comparison of tuberculin skin testing, Quanti FERON-TB gold and T-SPORT.TB in children. PloS One 2008; 3 (7): e2624.
12.	Shah M, Miele K, Choi H, DiPietro D, Martins-Evora M, Marsiglia V. QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis. BMC Infect Dis 2010; 12: 360.
13.	James PM, Ganaie FA, Kadahalli RL. The performance of quantiferon- TB gold in-Tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population. J Int Assoc Provid AIDS Care 2014; 13 (1): 47-55.
14.	Hemmati M, Ghadiri K, Rezaei M. Tuberculin reactivity in school age children; Five-year follow-up in Iran. Iran J Pediatr 2011; 21 (1): 39-44.
15.	Andronikon S, Smith B, Heatherhill M, Douis H, Wilmshurst J. Definitive neuro radiological diagnostic features of tuberculous meningitis in children. Pediatr Radiol 2004; 34 (11): 876-885.
16.	Delacourt C, Gobin J, Gaillard JL, de Blic, Veron M, Scheinmann P. Value of ELISA using antigen 60 for the diagnosis of tuberculosis in children. Chest 1993; 104 (2): 393-398.
17.	Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ. The natural history of childhood intra -thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8 (4): 392-402.
18.	National Institute for Health and Clinical Excellence (2011) Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. [Online] Available from: http://guidance.nice.org. uk/CG117 [Accessed on May 12th 2011].
19.	Munoz L, Santin M. Interferon-γ release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: an evidence-based review. J Infect 2013; 66 (4): 381-387.
20.	Vassilopoulos D, Tsikrika S, Hatzara C, Podia V, Kandili A, Stamoulis N. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy. Clin Vaccine Immunol 2011; 18 (12): 2012-2018.
21.	Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010; 59 (RR-5): 1-25.
22.	Eum SY, Lee YJ, Kwak HK, Min JH, Hawang SH, Via LE, et al. Evaluation of the diagnostic utility of a whole-blood interferon- gamma assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille calmette-Guerin (BCG)-vaccinated individuals. Diagon Microbiol Infec Dis 2008; 61 (2): 181-186.
23.	Pai M, Kalantri S, Dhedo K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. latent tuberculosis. Expert Rev Mol Diagn 2006; 6 (3): 413-422.
24.	Strarke JR. Interferon-gamma release assay for diagnosis of tuberculosis infection in children. Pediatr Infect Dis J 2006; 25 (10): 941-942.
25.	Ling DI, Crepeau CA, Dufresne M, Khan S, Quach C, Dendukuri N, et al. Evaluation of the impact of interferon-gamma release assays on the management of childhood tuberculosis. Pediatr Infect Dis J 2012; 31 (12): 1258-1262.
26.	Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H. Latent tuberculosis diagnosis in children by using the Quanti FERON-TB Gold In-Tube test. Pediatrics 2009; 123 (1): 30-37.
27.	Bamford AR, Crook AM, Clark JE, Nademi Z, Dixon G, Paton JY, et al. Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in UK: a pediatrics TB network study. Arch Dis Child 2010; 95 (3): 180-186.
28.	Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, Biggs BA. Comparison of Quanti FERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in health care staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol 2009; 30 (3): 251221.
29.	Alvarez-Leon EE, Espinosa-Vega E, Santana-Rodriguez E, Molina- Cabrillana JM, Perez-Arellano JL, Caminero JA. Screening for tuberculosis infection in Spanish health care workers: comparison of the Quanti FERON-TB gold in-tube test with the tuberculin skin test. Infect Control Hosp Pidemiol 2009; 30 (9): 876-883.
30.	Machado A Jr, Emodi K, Takenami I, Finkmoore BC, Barbosa T, Carvalho J. Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay. Int J Tuberc Lung Dis 2009; 13 (4): 446-453.
31.	Vaziri S, Khazaei S, Neishaboori SM, Molaei tavana P, Kanani M, Madani SH. The degree of agreement of quantiferon TB gold test and tuberculin skin test in nurses. J Gorgan Uni Med Sci 2010; 13 (1): 37-43.
32.	Pollock NR, Campos-Neto A, Kashino S, Napolitano D, Behar SM, Shin D. Discordant Quanti FERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol 2008; 29 (9): 878-886.
33.	Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individnds. Am J Respir Crit Care Med 2007; 175 (7): 737-742.
34.	Carvalho AC, Pezzoli MC, EI-Hamad I, Arce P, Bigoni S, Scarcella C. Quanti FERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect 2007; 55 (2): 164-168.